Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma

Pancreas

Volumn 41, Issue 1, 2012, Pages 114-120

  Takeshita, Akiko ^a   Kimura, Wataru ^a   Hirai, Ichiro ^a   Takasu, Naoki ^a   Moriya, Toshiyuki ^a   Tezuka, Koji ^a   Watanabe, Toshihiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

intraductal papillary mucinous neoplasms (IPMNs); IPMN with an associated invasive carcinoma; IPMN with high grade dysplasia; IPMN with low or intermediate grade dysplasia; MIB 1 labeling index (Ki67); ordinary ductal adenocarcinoma (ODA)

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; ORDINARY DUCTAL ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOTIC INDEX; PANCREAS; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84655174863     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318220c1fa     Document Type: Article

References (41)

1. Compagno J, Oerter JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). Am Soc Clin Pathol. 1978;69:573-580. (Pubitemid 8366915)
2. Le Borgne J, de Calan L, Partensky C, et al. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg. 1999;230:152-161. (Pubitemid 30191880)
3. Zamboni G, Scarpa A, Bogina C, et al. Mucinous cystic tumors of the pancreas. Am J Surg Pathol. 1999;23:410-422.
4. Kimura W, Makuuchi M, Kuroda A. Characteristics and treatment of mucin producing tumor of the pancreas. Hepatogastroenterology. 1998;45:2001-2008. (Pubitemid 29055767)
5. Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 1999;94:470-473. (Pubitemid 29084671)
6. Sohn TA, Yeo CJ, Cameron CL, et al. Intraductal papillary-mucinous neoplasms of the pancreas: an increasing recognized clinicopathological entity. Ann Surg. 2001;234:313-322. (Pubitemid 32847068)
7. Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas. Ann Surg. 2000;231:205-212.
8. Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004;28:241-246. (Pubitemid 38437316)
9. KimuraW. Histology of cystic tumors of the pancreas. In: Beger H, et al, eds. The Pancreas. An Integrated Textbook Basic Science, Medical and Surgery. 2nd ed. Massachusetts: Blackwell; 2008:893-911.
10. Takasu N, Kimura W, Moriya T, et al. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type. Pancreas. 2010;39:604-610.
11. Ohashi K, Murakami Y, Takekoshi T. Four cases of ïïmucin producingïï cancer of the pancreas on specific findings of the papilla of Vater [in Japanese]. Prog Dig Endosc. 1982;20:348-351.
12. Japan Pancreas Society. Classification of Pancreatic Cancer. 6th ed. Tokyo, Japan: Kanehara; 2009.
13. Solcia E, Capella C, Kloeppel G. Tumors of the Pancreas. Washington, DC: Armed Forces Institute of Pathology; 1997.
14. Kloppel G, Solcia E, Longnecker DS, et al. World Health Organization International Histological Classification of TumoursVHistological Typing of Tumors of the Exocrine Pancreas. 2nd ed. Corrected Printing. New York, NY: Springer; 1998.
15. Kimura W, Sasahira N, Yoshikawa T, et al. Duct-ectatic type of mucin producing tumor of the pancreas Y new concept of pancreatic neoplasia. Hepatogastroenterology. 1996;43:692-709. (Pubitemid 26190131)
16. Kimura W, Kuroda A, Makuuchi M. Problems in the diagnosis and treatment of a so-called mucin-producing tumor of the pancreas. Pancreas. 1998;16:363-369. (Pubitemid 28158042)
17. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2005;6:17-32.
18. Yanagisawa A, Ohashi K, Hori M, et al. Duct ectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: a novel clinicopathological entity. Jpn J Cancer Res. 1993;84:474-479. (Pubitemid 23136010)
19. Sasaki S, Yamamoto H, Kaneto H, et al. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep. 2003;10:21-25.
20. Semba S, Moriya T, Kimura W, et al. Phosphorylated Akt/PKB controls cell growth and invasive ductal adenocarcinoma of the pancreas. Pancreas. 2003;3:250-257.
21. Kimura W, Nagai H. Study of surgical anatomy for duodenum-preserving resection of the head of the pancreas. Ann Surg. 1995;221:359-363.
22. Kimura W. IHPBA in Tokyo, 2002: Surgical treatment of IPMT vs MCT: a Japanese experience. J Hepatobiliary Pancreat Surg. 2003;10(2):156-162. (Pubitemid 37160941)
23. Kimura W, Inoue T, Futakawa N, et al. Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein. Surgery. 1996;120:885-890. (Pubitemid 26378192)
24. Kimura W, Fuse A, Hirai I, et al. Spleen-preserving distal pancreatectomy with preservation of the splenic artery and vein for intraductal papillary-mucinous tumor (IPMT): three interesting cases. Hepatogastroenterology. 2003;50(54):2242-2245.
25. Kimura W, Fuse A, Hirai I, et al. Spleen-preserving distal pancreatectomy for intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology. 2004;51:86-90. (Pubitemid 38283065)
26. SauVanet A, Partensky C, Sastre B, et al. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery. 2002;132:836-843. (Pubitemid 36307822)
27. Kimura W, Makuuchi M. Operative indications for cystic lesions of the pancreas with malignant potentialVour experience. Hepatogastroenterology. 1999;46:483-491. (Pubitemid 29154803)
28. Moriya T, Kimura W, Sakurai F, et al. Minute invasive ductal carcinoma of the residual pancreas after distal pancreatectomy for intraductal papillary-mucinous tumor. Int J Gastrointestinal Cancer. 2002;31: 191-197. (Pubitemid 36330122)
29. Kataoka TR, Ioka T, Tsukamoto Y, et al. Nuclear expression of STST5 in intraductal papillary mucinous neoplasms of the pancreas. Int J Surg Pathol. 2007;15:277-281. (Pubitemid 46976543)
30. Okada T, Masuda N, Fukai Y, et al. Immunohistochemical expression of 14-3-3 C protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. Anticancer Res. 2006;26:3105-3110. (Pubitemid 44161807)
31. Abe K, Suda K, Arakawa A, et al. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas. 2007;34:85-91. (Pubitemid 46045725)
32. Okimura A, Hinano H, Nishigami T, et al. Immunohistochemical analyses of E cadherin, A-catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas. Med Mol Morphol. 2009;42:222-229.
33. Islam HK, Fujioka Y, Tomidokoro T, et al. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreasVdiagnostic and biologic significance. Hepatogastroenterology. 1999;46:2599-2605. (Pubitemid 29454150)
34. Terada T, Ohta T, Kitamura Y, et al. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas. Arch Pathol Lab Med. 1998;122:42-46. (Pubitemid 28212605)
35. DeLellis RA, Lloyd RV, Heitz PU, et al. Pathology and Genetics Tumor of Endocrine Organs. World Health Organization Classification of Tumors. Geneva, Switzerland: World Health Organization; 2004.
36. Viale G, Giobbie-Hurder A, Regan MM, et al. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from breast international group trial 1-98 comparing adjuVant tamoxifen with letrozole. J Clin Oncol. 2008;26:5569-5575.
37. Kamio Y, Maeda K, Moriya T, et al. Clinicopathological significance of cell cycle regulatory factors and differentiation-related factors in pancreatic tumors. Pancreas. 2010;39:345-352.
38. Wasif N, Bentrem DJ, Farrell JJ, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma. Cancer. 2010;116:3369-3377.
39. Nara S, Shimada K, Kosuge T, et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243-255. (Pubitemid 351172139)
40. Woo SM, Ryu JK, Lee SH, et al. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2008;36:50-55.
41. Murakami Y, Uemura K, Sudo T, et al. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol. 2009;100: 13-18.